Glancy prongay & murray llp, a leading securities fraud law firm, announces the filing of a securities class action on behalf of acadia pharmaceuticals inc. (acad) investors

Los angeles--(business wire)---- $acad #classaction--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired acadia pharmaceuticals inc. (“acadia” or the “company”) (nasdaq: acad) securities between june 15, 2020 and april 4, 2021, inclusive (the “class period”). acadia investors have until june 18, 2021 to file a lead plaintiff motion. if you suffered a loss on your acadia
ACAD Ratings Summary
ACAD Quant Ranking